Moolec Science (MLEC) Total Non-Current Liabilities (2022 - 2026)

Moolec Science (MLEC) reported Total Non-Current Liabilities of $93.1 million for Q1 2026, up 253.61% sequentially from $26.3 million in Q4 2025.

Moolec Science (MLEC) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

Moolec Science (MLEC) has 5 years of Total Non-Current Liabilities data on file, last reported at $93.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $93.1 million; the trailing twelve-month figure through Mar 2026 stood at $93.1 million (changed N/A YoY), and the FY2025 full-year result was $53.1 million, down 80.53% from the prior year.
  • Total Non-Current Liabilities advanced to $93.1 million in Q1 2026, from $26.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $272.4 million in Q2 2024 to a low of $621000.0 in Q2 2022.
  • A 5-year average of $44.1 million and a median of $19.5 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities soared 8858.23% in 2023 and tumbled 80.53% in 2025, its largest moves.
  • Tracing MLEC's Total Non-Current Liabilities over 5 years: stood at $9.6 million in 2022, then plunged by 33.88% to $6.4 million in 2023, then surged by 248.16% to $22.1 million in 2024, then advanced by 18.99% to $26.3 million in 2025, then jumped by 253.61% to $93.1 million in 2026.
  • Business Quant data shows MLEC's Total Non-Current Liabilities at $93.1 million in Q1 2026, $26.3 million in Q4 2025, and $53.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Moolec Science 5.21 Bn 5.21 Bn - 93.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 93.10 Mn
Dec 31, 2025 26.33 Mn
Jun 30, 2025 53.05 Mn
Dec 31, 2024 22.13 Mn
Sep 30, 2024 19.50 Mn
Jun 30, 2024 272.43 Mn
Mar 31, 2024 11.49 Mn
Dec 31, 2023 6.36 Mn
Sep 30, 2023 1.09 Mn
Jun 30, 2023 55.63 Mn
Mar 31, 2023 1.59 Mn
Dec 31, 2022 9.61 Mn
Jun 30, 2022 621,000.00